No abstract available
Publication types
-
Comparative Study
-
Editorial
MeSH terms
-
Animals
-
Antineoplastic Agents / pharmacology
-
Antineoplastic Agents / therapeutic use
-
Clinical Trials as Topic
-
Humans
-
Mammals
-
Mechanistic Target of Rapamycin Complex 1
-
Multiprotein Complexes
-
Neoplasms / drug therapy*
-
Neoplasms / enzymology*
-
Phosphoinositide-3 Kinase Inhibitors
-
Phosphorylation / drug effects
-
Protein Kinase Inhibitors / therapeutic use*
-
Protein Kinases / metabolism
-
Proteins / antagonists & inhibitors
-
Proto-Oncogene Proteins c-akt / antagonists & inhibitors
-
Signal Transduction / drug effects
-
Sirolimus / analogs & derivatives
-
Sirolimus / pharmacology
-
Sirolimus / therapeutic use*
-
TOR Serine-Threonine Kinases / antagonists & inhibitors*
-
TOR Serine-Threonine Kinases / metabolism
-
Transcription Factors / antagonists & inhibitors
Substances
-
Antineoplastic Agents
-
CRTC2 protein, human
-
Multiprotein Complexes
-
Phosphoinositide-3 Kinase Inhibitors
-
Protein Kinase Inhibitors
-
Proteins
-
Transcription Factors
-
Protein Kinases
-
MTOR protein, human
-
Mechanistic Target of Rapamycin Complex 1
-
Proto-Oncogene Proteins c-akt
-
TOR Serine-Threonine Kinases
-
Sirolimus